A prognostic model for 1 year change in 4SC
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy
Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy
Categorising trajectories and individual item changes of the NSAA in patients with DMD
Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy
Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy. Goemans N*, Vanden Hauwe M, Signorovitch J, Swallow E, Song J; Collaborative Trajectory Analysis Project (cTAP). PLoS One. 2016 Oct 13;11(10):e0164684. doi: 10.1371/journal.pone.0164684. eCollection 2016 1 University Hospitals Leuven, Child Neurology, Leuven, Belgium, 2 Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, Massachusetts, United States of America, 3 The Trajectory Analysis Project (TAP) Collaboration, One Broadway, 14th floor, Cambridge, Massachusetts,…
Supplemental Materials on Neuromuscular Disorders
View the Full PDF
Categorizing natural history trajectories of ambulatory function
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy. Mercuri E, Signorovitch JE, Swallow E, Song J, Ward SJ; DMD Italian Group; Trajectory Analysis Project (cTAP). Neuromuscul Disord. 2016 Sep;26(9):576-83. doi: 10.1016/j.nmd.2016.05.016. Epub 2016 May 27 Eugenio Mercuri a,*, James Edward Signorovitch b,c, Elyse Swallow b, Jinlin Song b, Susan J. Ward c for the DMD Italian Group # and the collaborative Trajectory Analysis Project…